Summary: On July 17, ISDA’s accounting committee responded to the European Commission’s (EC) consultation on ‘Fitness Check on the EU Framework for Public Reporting by Companies’. ISDA’s members stressed that the main objective of IFRS is to provide useful information to investors, lenders and other creditors to assist them in making decisions about buying, selling, settling or holding equity and debt instruments and other forms of credit. The IFRS is not – and should not be – designed to ensure financial stability or to promote sustainability. The main achievements of IFRS have been to help develop cross-border markets within the EU and across the globe. A single accounting framework has strengthened confidence in financial reporting, reduced the costs of reporting for entities with multinational operations and promoted the free movement of accounting personnel.
Documents (1) for ISDA responds to EC Consultation on Fitness Check on EU Framework for Public Reporting
Latest
ISDA AGM Studio: Darcy Bradbury & Tyler Wellensiek
Darcy Bradbury, ISDA board member and managing director at D. E. Shaw, and Tyler Wellensiek, managing director and global head of market structure at BlackRock, speaks with Chris Young, ISDA’s head of US public policy, about how the post‑crisis regulatory...
Response to ESMA Guarantees
On April 30, ISDA responded to the European Securities and Markets Authority (ESMA) consultation paper on guarantees as central counterparty (CCP) collateral and certain aspects of CCP investment policy. ISDA broadly supports ESMA’s proposed draft regulatory technical standards (RTS) to...
ISDA AGM Studio: Jenny Cosco and Jason Granet
Jenny Cosco, global head of government relations and regulatory strategy at LSEG, and Jason Granet, chief investment officer at BNY, speak with Tara Kruse, ISDA’s global head of derivative products and infrastructure, about how firms can manage liquidity pressures during...
Updated OTC Derivatives Compliance Calendar
ISDA has updated its global calendar of compliance deadlines and regulatory dates for the over-the-counter (OTC) derivatives space.